drugset / Trial / NCT00004106
Temozolomide in Treating Patients With Mycosis Fungoides or Sezary Syndrome
Non-randomizedSingle-groupOpen-labelTreatment
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. PURPOSE: This phase II trial is studying temozolomide to see how well it works in treating patients with mycosis fungoides or Sezary syndrome that has not responded to previous treatment.
Timeline
- Start
- 1998-05
- Primary completion
- 2006-04
- Completion
- 2006-04
Outcome
Outcome not reported
Stopped (Enrollment): “Per Data Monitoring Committee given the poor/inadequate accrual.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Temozolomide | Small molecule | 150 mg/m2 | Oral |